Empowering Parkinson’s Disease Management Through Mobile Applications: A Systematic Review and Meta-Analysis
DOI:
https://doi.org/10.30953/thmt.v11.676Keywords:
mental health, mobile applications, Parkinson’s disease, physical functionAbstract
Introduction: Although numerous mobile applications have been developed for Parkinson's disease, their effectiveness in improving clinical outcomes remains uncertain.
Objective: This systematic review aimed to evaluate the effectiveness of mobile applications for Parkinson's disease in both diagnosis and self-management.
Methods: A review of the literature was conducted using PubMed, Ovid Medline, Scopus, ScienceDirect, Cochrane Library, and EMBASE for articles related to mobile applications in Parkinson’s Disease published between 2011 and 10 November 2024. This systematic review and meta-analyses were performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The quality of the selected studies was assessed.
Results: Nineteen studies involving 1080 participants across ten countries were included in this review. These studies included 15 cross-sectional studies and 4 randomized-controlled trials. Mobile applications were used for symptom monitoring, medication reminders, exercise, rehabilitation, and diagnosis of Parkinson's disease. A meta-analysis of four randomized controlled trials found no significant difference between mobile application interventions and control groups (overall standard mean difference = –1.12, 95% CI –5.53 to 3.29, p = 0.62). Subgroup analyses revealed no significant effect for either motor (standard mean difference = 0.02, 95% CI –0.41 to 0.46, p=0.91) or non-motor symptoms (standard mean difference = –777.73, 95% CI –2306.27 to 750.80, p=0.32).
Conclusion: Due to the limited number and heterogeneity of existing studies, the evidence regarding to the effectiveness of mobile applications in Parkinson's disease remain inconclusive. Further research is needed to strengthen the evidence and assess the clinical benefits of mobile applications in the management of Parkinson's disease.
Downloads
References
1. Kalia L V., Lang AE. Parkinson’s disease. Vol. 386, The Lancet. Lancet Publishing Group; 2015. p. 896–912.
2. Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, et al. Past, present, and future of Parkinson’s disease: A special essay on the 200th Anniversary of the Shaking Palsy. Vol. 32, Movement Disorders. John Wiley and Sons Inc; 2017. p. 1264–310.
3. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson’s disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5).
4. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson’s disease. Vol. 18, Nature Reviews Neuroscience. Nature Publishing Group; 2017. p. 435–50.
5. Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari GS, et al. Quality of life in Parkinson’s disease: A systematic review and meta-analysis of comparative studies. Vol. 27, CNS Neuroscience and Therapeutics. Blackwell Publishing Ltd; 2021. p. 270–9.
6. Al-Khammash N, Al-Jabri N, Albishi A, Al-Onazi A, Aseeri S, Alotaibi F, et al. Quality of Life in Patients With Parkinson’s disease: A Cross-Sectional Study. Cureus. 2023 Jan 20;
7. Hoseinipalangi Z, Kan FP, Hosseinifard H, Doustmehraban M, Masoumi M, Rafiei S, et al. Systematic review and meta-analysis of the quality-of-life of patients with parkinson’s disease. Vol. 29, Eastern Mediterranean Health Journal. World Health Organization; 2023. p. 63–70.
8. Yi ZM, Willis S, Zhang Y, Liu N, Tang QY, Zhai S Di. Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson’s disease. Front Pharmacol. 2022 Jan 3;12.
9. Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ. Loss of ability to work and ability to live independently in Parkinson’s disease. Parkinson’sism Relat Disord. 2012 Feb;18(2):130–5.
10. Gerlach OHH, Winogrodzka A, Weber WEJ. Clinical problems in the hospitalized Parkinson’s disease patient: Systematic review. Vol. 26, Movement Disorders. 2011. p. 197–208.
11. Low V, Ben-Shlomo Y, Coward E, Fletcher S, Walker R, Clarke CE. Measuring the burden and mortality of hospitalisation in Parkinson’s disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013. Parkinson’sism Relat Disord. 2015 May 1;21(5):449–54.
12. Sjödahl Hammarlund C, Westergren A, Åström I, Edberg AK, Hagell P. The Impact of Living with Parkinson’s disease: Balancing within a Web of Needs and Demands. Parkinson’ss Dis. 2018;2018.
13. Morgan C, Rolinski M, McNaney R, Jones B, Rochester L, Maetzler W, et al. Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson’s disease in the Home or a Home-like Environment. Vol. 10, Journal of Parkinson’s disease. IOS Press; 2020. p. 429–54.
14. Luis-Martínez R, Monje MHG, Antonini A, Sánchez-Ferro Á, Mestre TA. Technology-Enabled Care: Integrating Multidisciplinary Care in Parkinson’s disease Through Digital Technology. Vol. 11, Frontiers in Neurology. Frontiers Media S.A.; 2020.
15. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Vol. 372, BMJ. BMJ Publishing Group; 2021.
16. Linares-del Rey M, Vela-Desojo L, Cano-de la Cuerda R. Mobile phone applications in Parkinson’s disease: A systematic review. Vol. 34, Neurologia. Spanish Society of Neurology; 2019. p. 38–54.
17. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. The BMJ. 2019;366.
18. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Online). 2016;355.
19. Arora S, Venkataraman V, Zhan A, Donohue S, Biglan KM, Dorsey ER, et al. Detecting and monitoring the symptoms of Parkinson’s disease using smartphones: A pilot study. Parkinson’sism Relat Disord. 2015 Jun 1;21(6):650–3.
20. Kassavetis P, Saifee TA, Roussos G, Drougkas L, Kojovic M, Rothwell JC, et al. Developing a Tool for Remote Digital Assessment of Parkinson’s disease. Mov Disord Clin Pract. 2016 Jan 1;3(1):59–64.
21. Pan D, Dhall R, Lieberman A, Petitti DB. A mobile cloud-based Parkinson’s disease assessment system for home-based monitoring. JMIR Mhealth Uhealth. 2015 Mar 26;3(1):e29.
22. Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, et al. Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease. NPJ Parkinson’ss Dis. 2017 Dec 1;3(1).
23. Tsiouris KM, Gatsios D, Rigas G, Miljkovic D, Seljak BK, Bohanec M, et al. PD-Manager: An mHealth platform for Parkinson’s disease patient management. Healthc Technol Lett. 2017;4(3):102–8.
24. Elm JJ, Daeschler M, Bataille L, Schneider R, Amara A, Espay AJ, et al. Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson’s disease data. NPJ Digit Med. 2019 Dec 1;2(1).
25. Marano M, Motolese F, Rossi M, Magliozzi A, Yekutieli Z, Di Lazzaro V. Remote smartphone gait monitoring and fall prediction in Parkinson’s disease during the COVID-19 lockdown. Neurological Sciences. 2021 Aug 1;42(8):3089–92.
26. Pierce A, Ignasiak NK, Eiteman-Pang WK, Rakovski C, Berardi V. Mobile phone sensors can discern medication-related gait quality changes in Parkinson’s patients in the home environment. Computer Methods and Programs in Biomedicine Update. 2021 Jan 1;1.
27. Rosenblum S, Richardson A, Meyer S, Nevo T, Sinai M, Hassin-Baer S. Dailycog: A real-world functional cognitive mobile application for evaluating mild cognitive impairment (mci) in Parkinson’s disease. Sensors. 2021 Mar 1;21(5):1–14.
28. Bendig J, Wolf AS, Mark T, Frank A, Mathiebe J, Scheibe M, et al. Feasibility of a Multimodal Telemedical Intervention for Patients with Parkinson’s disease—A Pilot Study. J Clin Med. 2022 Feb 1;11(4).
29. Gaßner H, Friedrich J, Masuch A, Jukic J, Stallforth S, Regensburger M, et al. The Effects of an Individualized Smartphone-Based Exercise Program on Self-defined Motor Tasks in Parkinson’s disease: Pilot Interventional Study. JMIR Rehabil Assist Technol. 2022 Dec 1;9(4).
30. Park Y, Kim SR, So HY, Jo S, Lee SH, Hwang Y su, et al. Effect of mobile health intervention for self-management on self-efficacy, motor and non-motor symptoms, self-management, and quality of life in people with Parkinson’s disease: Randomized controlled trial. Geriatr Nurs (Minneap). 2022 Jul 1;46:90–7.
31. Khachian A, Zeighami K, Khoubbin Khoshnazar TA, Haghani H. The Effectiveness of Self-Management Education Based on the Mobile Application on the Quality of Life of People with Parkinson’s disease. Middle East Journal of Rehabilitation and Health Studies. 2023 Apr 1;10(2).
32. Lützow L, Teckenburg I, Koch V, Marxreiter F, Jukic J, Stallforth S, et al. The effects of an individualized smartphone-based exercise program on self-defined motor tasks in Parkinson’s disease: a long-term feasibility study. J Patient Rep Outcomes. 2023 Dec 1;7(1).
33. Ahn JH, Shin D, Lee D, Kim HY, Youn J, Cho JW. Increasing exercise with a mobile app in people with Parkinson’s disease: A pilot study. Brain Impairment. 2024 Mar 22;25(2).
34. Lee JH, Yeom I, Chung ML, Kim Y, Yoo S, Kim E. Use of Mobile Apps for Self-care in People with Parkinson’s disease: Systematic Review. Vol. 10, JMIR mHealth and uHealth. JMIR Publications Inc.; 2022.
35. Maggio MG, Luca A, Cicero CE, Calabrò RS, Drago F, Zappia M, et al. Effectiveness of telerehabilitation plus virtual reality (Tele-RV) in cognitive e social functioning: A randomized clinical study on Parkinson’s disease. Parkinson’sism Relat Disord. 2024 Feb 1;119.
36. Marsili L, Abanto J, Mahajan A, Duque KR, Chinchihualpa Paredes NO, Deraz HA, et al. Dysrhythmia as a prominent feature of Parkinson’s disease: An app-based tapping test. J Neurol Sci. 2024 Aug 15;463.
37. Ginis P, Nieuwboer A, Dorfman M, Ferrari A, Gazit E, Canning CG, et al. Feasibility and effects of home-based smartphone-delivered automated feedback training for gait in people with Parkinson’s disease: A pilot randomized controlled trial. Parkinson’sism Relat Disord. 2016 Jan 1;22:28–34.
38. Lee JH, Suh Y, Kim E, Yoo S, Kim Y. A Mobile App for Comprehensive Symptom Management in People With Parkinson’s disease: A Pilot Usability Study. CIN - Computers Informatics Nursing. 2024 Apr 24;42(4):289–97.
39. Espay AJ, Hausdorff JM, Sánchez-Ferro Á, Klucken J, Merola A, Bonato P, et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson’s disease obtained using mobile health technologies. Vol. 34, Movement Disorders. John Wiley and Sons Inc.; 2019. p. 657–63.
40. Global Strategy on Digital Health 2020-2025. World Health Organization; 2021.
41. Yin W, Gao H, Liang B, Liu R, Liu Y, Shen C, et al. Quantitative analysis of gait parameters in Parkinson’s disease and the clinical significance. Front Neurol. 2025;16.
42. Muñoz DA, Kilinc MS, Nembhard HB, Tucker C, Huang X. Evaluating the cost-effectiveness of an early detection of Parkinson’s disease through innovative technology. Engineering Economist. 2017 Apr 3;62(2):180–96.
43. Del Pino R, Díez-Cirarda M, Ustarroz-Aguirre I, Gonzalez-Larragan S, Caprino M, Busnatu S, et al. Costs and effects of telerehabilitation in neurological and cardiological diseases: A systematic review. Vol. 9, Frontiers in Medicine. Frontiers Media S.A.; 2022.
44. Twala B. AI-driven precision diagnosis and treatment in Parkinson’s disease: a comprehensive review and experimental analysis. Front Aging Neurosci. 2025 Jul 28;17.
45. Islam MS, Rahman W, Abdelkader A, Lee S, Yang PT, Purks JL, et al. Using AI to measure Parkinson’s disease severity at home. NPJ Digit Med. 2023 Dec 1;6(1).
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mei Wah Lee, MSc, Umar Idris Ibrahim, PhD, Pei Lin Lua, PhD
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Telehealth and Medicine Today (THMT).
THMT is published under a Creative Commons Attribution-NonCommercial 4.0 International License.
